Cargando…
OptMAVEn – A New Framework for the de novo Design of Antibody Variable Region Models Targeting Specific Antigen Epitopes
Antibody-based therapeutics provides novel and efficacious treatments for a number of diseases. Traditional experimental approaches for designing therapeutic antibodies rely on raising antibodies against a target antigen in an immunized animal or directed evolution of antibodies with low affinity fo...
Autores principales: | Li, Tong, Pantazes, Robert J., Maranas, Costas D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143332/ https://www.ncbi.nlm.nih.gov/pubmed/25153121 http://dx.doi.org/10.1371/journal.pone.0105954 |
Ejemplares similares
-
OptMAVEn-2.0: De novo Design of Variable Antibody Regions against Targeted Antigen Epitopes
por: Chowdhury, Ratul, et al.
Publicado: (2018) -
Concerns with computational protein engineering programmes IPRO and
OptMAVEn and metabolic pathway engineering programme optStoic
por: Wood, Thomas K.
Publicado: (2021) -
MAPs: a database of modular antibody parts for predicting tertiary structures and designing affinity matured antibodies
por: Pantazes, Robert J, et al.
Publicado: (2013) -
OptZyme: Computational Enzyme Redesign Using Transition State Analogues
por: Grisewood, Matthew J., et al.
Publicado: (2013) -
OptCom: A Multi-Level Optimization Framework for the Metabolic Modeling and Analysis of Microbial Communities
por: Zomorrodi, Ali R., et al.
Publicado: (2012)